Pharma Press Releases

Emergence of Digital Technologies in Pharmaceutical Industry

Positive Phase II Results, Ongoing Phase III Trial, and Cash Runway Into Late-2027 Positions Cardiol Therapeutics Inc. (N A S D A Q: CRDL) $CRDL for Transformational Growth

$LNAI is Deploying their patented AI architecture, launches national defense consortium, and accelerates 3-year antidote development model to capture $400M–$1.2B federal opportunities

Accelerating scalable AI infrastructure, secures up to $9.75M financing, and advances FDA-registered diagnostic technology alongside next-generation generative AI platforms $ALBT

How Pharma Quality Leaders Are Rethinking Accountability in an AI-Driven Environment For many years, inspection readiness in pharma meant one thing: preparation.

Biobase, a healthcare data infrastructure company pioneering the first agentic operating system for clinical data, received a strategic investment from BJC Health that will position BJC as a center of excellence for deploying next-generation AI solutions.

Pharma Now is a leading monthly B2B magazine focused on delivering in-depth content related to the pharmaceutical and biopharma sectors.

Driving Breakthroughs from Drug Discovery and Development to AI in Pharma

GlobalSpace Technologies Ltd announces the launch of PATGPT, a pharma-specific Large Language Model (LLM) platform. PATGPT will operate under a hybrid model where 50% of the model training is already done by GlobalSpace

Twin Eagle Trade and Makland Pharmaceuticals Launch Global Pharma Alliance to Transform Healthcare Access in West Africa.

The First AI Pharmacist Aims to Tackle Medication Errors and Support Healthcare Professionals

Compliance Group Inc. is excited to present Part 2 of its impactful webinar series, "AI Governance Strategic Imperative in MedTech," titled "Regulatory Perspective (FDA Focus)." Scheduled for Tuesday, August 27, 2025, from 11:00–11:45 AM EST, this live...

India's pharmaceutical industry, a global leader, offers fertile ground for new ventures. However, this highly regulated sector demands thorough planning and strict adherence to established guidelines.

First Choice Neurology is proud to announce a groundbreaking partnership with NeuroDiscovery AI (NDAI), a national leader in artificial intelligence, data analytics, and clinical dashboarding for neurology.

Learn more about the potential of using AI tools for drug discovery as well as the risks this new technology could have.

Trials have the potential to fast-track treatment options for patients with limited therapeutic alternatives

Nomas Global Investments LLC, a SPV of H.H.Shaikh Mohammed Bin Sultan Bin Hamdan Al Nahyan, is a member of Royal Family of Abu Dhabi

Precision Quantomics Inc. Awarded NIH STTR Grant to Address Health Disparities through Quantitative Physiological Database and Precision Systems Modeling